Download FREE Report Sample
Download Free sampleEquine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable.
Equine Rabies Immunoglobulin Market contains market size and forecasts of Equine Rabies Immunoglobulin (ERIG) in global, including the following market information:
Global Equine Rabies Immunoglobulin (ERIG) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Equine Rabies Immunoglobulin (ERIG) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Equine Rabies Immunoglobulin (ERIG) companies in 2021 (%)
The global Equine Rabies Immunoglobulin (ERIG) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1500IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Equine Rabies Immunoglobulin (ERIG) include Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Equine Rabies Immunoglobulin (ERIG) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Equine Rabies Immunoglobulin (ERIG) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Equine Rabies Immunoglobulin (ERIG) Market Segment Percentages, by Type, 2021 (%)
1500IU
1000IU
400IU
Other
Global Equine Rabies Immunoglobulin (ERIG) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Equine Rabies Immunoglobulin (ERIG) Market Segment Percentages, by Application, 2021 (%)
Category II Exposure
Category III Exposure
Global Equine Rabies Immunoglobulin (ERIG) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Equine Rabies Immunoglobulin (ERIG) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Equine Rabies Immunoglobulin (ERIG) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Equine Rabies Immunoglobulin (ERIG) revenues share in global market, 2021 (%)
Key companies Equine Rabies Immunoglobulin (ERIG) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Equine Rabies Immunoglobulin (ERIG) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
